Oncologic Outcomes of Robotic-Assisted Total Mesorectal Excision for the Treatment of Rectal Cancer
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In Brief Objective: To evaluate local recurrence and survival after robotic-assisted total mesorectal excision (RTME) for primary rectal cancer. Summary Background Data: RTME is a novel approach for the treatment of rectal cancer and has been shown to be safe and effective. However, the oncologic results of this approach have not been reported in terms of local recurrence and survival rate. Methods: Sixty-four consecutive rectal cancer patients with stage I–III disease treated between November 2004 and June 2008 were analyzed prospectively. Results: All patients underwent RTME: 34 had colorectal anastomosis, 18 underwent coloanal anastomosis, and 12 received abdominoperineal resection. Operative mortality rate was 0%. The median operative time was 270 min and median blood loss was 200 mL. The conversion rate was 9.4%. Anastomotic leakage occurred in 4 of 52 (7.7%) patients with anastomosis. Median number of harvested lymph nodes was 14.5. Median distal margin of tumor was 3.4 cm. The circumferential resection margin was negative in all surgical specimens. No port-site recurrence occurred in any patient. Six patients developed recurrence: 2 combined local and distant, and 4 distal alone (mean follow-up of 20.2 months; range, 1.7–52.5). None of the patients developed isolated local recurrence. The mean time to local recurrence was 23 months. The 3-year overall and disease-free survival rates were 96.2% and 73.7%, respectively. Conclusions: RTME can be carried out safely and effectively in terms of recurrence and survival rates. Further prospective randomized trials are necessary to better define the absolute benefits and limitations of robotic rectal surgery. We prospectively evaluated local recurrence and survival after robotic-assisted total mesorectal excision for rectal cancer. We found that robotic-assisted total mesorectal excision is technically feasible and oncologically safe. It can be performed with negative resection margins and results in early return of bowel function, short hospital stay, and adequate oncologic outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050 · cited 1×
“The 5-year overall and disease free-survival after open rectal surgery in patients who underwent preoperative chemoradiotherapy was 76% and 68%, respectively.(35) The 3-year overall and disease-free survivals in our study were comparable to those of previous study of laparoscopic and open rectal surgery (Table 4).”
Result
Cited by
Trastulli, S., Farinella, E., Cirocchi, R., Cavaliere, D., Avenia, N., Sciannameo, F., Gullà, N., Noya, G., & Boselli, C. (2012) · Colorectal Disease · doi:10.1111/j.1463-1318.2011.02907.x · Cited by 298
Collinson, F. J., Jayne, D. G., Pigazzi, A., Tsang, C., Barrie, J. M., Edlin, R., Garbett, C., Guillou, P., Holloway, I., Howard, H., et al. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1313-6 · Cited by 255
Self-citation
Metadata
- Authors
- Baek, J.-H., McKenzie, S., Garcia-Aguilar, J., & Pigazzi, A.
- Venue
- Annals of Surgery
- Published
- 2010-05
- Volume
- 251
- Issue
- 5
- Pages
- 882-886
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2080817156
- Cited by
- 161
- References
- 1
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oncologic Outcomes of Robotic-Assisted Total Mesorectal Excision for the Treatment of Rectal Cancer. https://app.cochat.ai/papers/10.1097/sla.0b013e3181c79114
- The paper
- Baek, J.-H., McKenzie, S., Garcia-Aguilar, J., & Pigazzi, A. (2010). Oncologic Outcomes of Robotic-Assisted Total Mesorectal Excision for the Treatment of Rectal Cancer. Annals of Surgery. https://doi.org/10.1097/sla.0b013e3181c79114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.